WallStSmart
SRRK

Scholar Rock Holding Corp

NASDAQ: SRRK · HEALTHCARE · BIOTECHNOLOGY

$44.18
-1.14% today

Updated 2026-06-12

Market cap
$5.29B
P/E ratio
P/S ratio
13.14x
EPS (TTM)
$-3.45
Dividend yield
52W range
$27 – $52
Volume
1.4M

Scholar Rock Holding Corp (SRRK) Financial statements

SEC filings — annual and quarterly data.

Profit margin
0.00%
Operating margin
0.00%
ROE
-148.08%
ROA
-54.30%
Debt/equity
0.75x

Margin trends — annual

Gross margin Operating margin Profit margin
YearRevenueNet incomeGross marginOp. marginProfit margin
2016$379000.00$-16.21M-3,192.08%-4,277.04%-4,276.25%
2017$0.00$-25.00M
2018$0.00$-49.33M
2019$20.49M$-49.70M100.00%-266.16%-242.52%
2020$15.40M$-84.99M100.00%-564.03%-551.79%
2021$18.82M$-131.80M-476.47%-690.48%-700.46%
2022$33.19M$-131.65M100.00%-404.81%-396.61%
2023$0.00$-165.79M
2024$0.00$-246.29M
2025$0.00$-377.94M

Frequently asked questions

How much free cash flow does SRRK generate?

SRRK produced $-300.64M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is SRRK's balance sheet healthy?

SRRK holds $323.53M in cash and equivalents against $99.71M in long-term debt, on $245.49M of shareholder equity. Cash on hand exceeds long-term debt, so the balance sheet adds little financial risk to the thesis.